We have developed a cell culture procedure that can produce large quantities of confluent monolayers of primary human fetal retinal pigment epithelium (hfRPE) cultures with morphological, physiological and genetic characteristics of native human RPE. These hfRPE cell cultures exhibit heavy pigmentation, and electron microscopy show extensive apical membrane microvilli. The junctional complexes were identified with immunofluorescence labeling of various tight junction proteins. Epithelial polarity and function of these easily reproducible primary cultures closely resemble previously studied mammalian models of native RPE, including human. These results were extended by the development of therapeutic interventions in several animal models of human eye disease. We have focused on strategies for the removal of abnormal fluid accumulation in the retina or subretinal space. The extracellular subretinal space separates the photoreceptor outer segments and the apical membrane of the RPE and is critical for maintenance of retinal attachments and a whole host of RPE/retina interactions.
All human tissue related research follows the tenets of the Declaration of Helsinki and the NIH institutional review board. Fetal eyes are obtained by an independent procurer, Advanced Bioscience Resources (ABR, Alameda, CA), from random donors at 16 to 22 weeks of gestation, placed in RPMI-1640 media containing tubes (provided by ABR), packed on ice, and delivered by an overnight priority delivery service. Tissues remain viable up to 48 hours after enucleation.
Cell Culture Medium
MEM-alpha modified medium (Sigma-Aldrich) is used as the base medium to prepare 5% and 15% serum-containing media for culturing of RPE cells (RPE medium; Table 1 Fetal bovine serum used in media preparation is obtained from Atlanta Biologicals (Norcross, GA). Each bottle of the serum is heat inactivated (56°C for 1hr) prior to use. To ensure cell culture consistency large amounts of serum from the same lot are purchased and stored in -20°C until they are used for media preparation. Sparsely seeded cells from a specific batch of hfRPE cells are grown in 24-or 12-well plates for a few weeks in media containing 20% FBS from different lots. The fastest growing melanated cells with the most classical RPE morphology (cobblestone) indicate an appropriate serum lot that can be used for cell culture.
Cell culture medium also contains: N1 supplement (Sigma-Aldrich) 1:100 mL/mL, GlutaMax/ penicillin-streptomycin 1:100 mL/mL (Gibco), and nonessential amino acid solution (Sigma-Aldrich) 1:100 mL/mL. In addition, hydrocortisone (20 μg/L), taurine (250 mg/L), and triiodo-thyronin (0.013 μg/L) (THT) is prepared ahead by dissolving these three components in PBS to a final concentration of 1:500 (mL/mL). Aliquots of THT are stored at 80°C until added to the RPE medium.
Cell Culture
On receipt, intact globes are rinsed in antibiotic antimycotic solution (diluted to 10X; cat. no. 15240-096; Invitrogen) plus gentamicin (1 mg/mL) for 3 to 5 minutes (Figure 1 below).
Figure 1.
After incubation antibiotics are rinsed off twice with medium such as HBSS or PBS. One eye globe at the time is transferred to 10 cm Petri dish with coated with Sylgard-184 (WPI) and secured with 27G needles. Using ClearCut sideport knife (Alcon) an incision is made through the sclera below the ciliary body (1/3 of the distance from eye equator to the anterior surface). This incision is used to start a circular cut for removal of the anterior eye portion. This cut is made using a tungsten-carbide coated curved iris scissors with one blade serrated (FST). Prior to the removal of the anterior part of the eye, a cut is made through the vitreous body to avoid detaching the retina from the RPE at the posterior pole. After the anterior portion of the eye is removed, the posterior pole is incubated with dispase-I solution (2 U/mL, cat. no. 04942086001; Roche Diagnostics, Indianapolis, IN) in 5% serum containing medium for 40-60 minutes in 37°C-5% CO 2 . After dispase treatment, the posterior poles are transferred to a HBSS in Petri dishes with silicon padding (Sylgard 184; Dow Corning, Midland, MI) and dissected into quadrants or larger pieces to sufficiently flatten tissues. Then the retina is gently removed with forceps. Single-cell RPE layers were peeled off in sheets and collected directly into cold trypsin-EDTA (Gibco, #25200-056) solution. After the RPE are collected, tubes with tissues in trypsin-EDTA are sealed and transferred into water bath for 10-15 mins at 37°C. After 10 mins of incubation, the tubes are vigorously shaken to separate RPE into small clusters. If the separation is not complete, the tubes are placed back into water bath for another 5 mins. After trypsin-EDTA incubation, the tubes are inspected for possible un-dissolved mixed cell clusters. Any observed clusters are removed using fine tipped glass Pasteur pipette. After spinning down (1.4 rpm on clinical centrifuge for 4 mins), hfRPE cells are re-suspended in 15% RPE media and then put into Primaria flasks (example: cat. no. 08-772-45; Fisher Scientific, Pittsburgh, PA). This medium is replaced after 1 day with 5% serum-containing RPE medium, and subsequent changes were made every 2 to 3 days. After 3 to 4 weeks, the cells became confluent and uniformly pigmented. They are then trypsinized in 0.25% trypsin-EDTA for 10 to 15 minutes, re-suspended in 15% serum-containing RPE cell culture medium, and seeded onto clear cell culture inserts at 150 to 200K cells per well (Transwell; Corning Costar, Corning, NY), using 12-mm diameter inserts, 0.4-um pores, polyester membranes (example: cat. no. 07-200-161, Fisher Scientific). Before seeding, the wells were coated with human extracellular matrix (10 μg in 150 μL HBSS per well, cat. no. 354237; BD Biosciences, Franklin Lakes, NJ) and cured with UV light in the hood for 2 hours. In some cases, the trypsinization procedure was repeated for a second time, to collect the cells that did not detach after the first trypsinization. The same protocol (excluding coating with ECM) was used to culture cells on the flasks to generate the P1 population of cells. These cells were used in experiments when they had a total tissue resistance of ≥ 200 Ω•cm 2 and were uniformly pigmented.
Please click here for a larger figure 1.
Step by Step Procedures

Representative Results
Functional validation of hfRPE cell culture
In previous experiments we have used these primary cultures to determine the expression, polarization and function of plasma membrane transport proteins and identify specific signaling pathways that regulate RPE function [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] These characteristics as they are accumulated provide a validation set of properties that can be applied to each cell generation. The experiments summarized below identify the proteins that determine transepithelial fluid transport and the integrity of the paracellular pathway. These in vitro experiments have been validated in an animal model of retinal re-reattachment Below is an example of animal model experiments confirming hfRPE in vitro findings. In this experiment, artificially created retinal detachment was significantly reduced after addition of IFNg to the exterior eye surface (Figure 4 A,B ). This effect can be partially blocked by: (1) addition of cAMP blocker ( Figure 4D ); (2) completely blocked after addition of JAK + cAMP blockers. Images below are obtained using OCT scanner. 
Discussion
In the present experiments, we describe additional modifications of our previously published techniques 3 designed to streamline the multiple steps needed to produce consistent hfRPE primary cultures with a higher numbers of available cells per eye. Each change in the original procedure was rigorously tested in multiple physiology and molecular biology experiments to ensure that the changes did not introduce artifacts and being continually tested by many other labs using these cells. Finally, additional experiments were carried out to compare the in vitro results to similar perturbations in animal models.
